Home
The Peter Attia Drive
Home
#75 - David Light: Zantac recall due to cancer concerns – what you need to know
01:37:30
Share
2019/10/14
The Peter Attia Drive
Request Transcript
Frequently requested episodes will be transcribed first
Chapters
What inspired the creation of Valisure, an online pharmacy that tests all medications?
The valsartan recall: How did Valisure contribute?
Testing Zantac: What were the alarming results from Valisure’s initial tests?
NDMA in Zantac/ranitidine: What is the risk?
Are we overinterpreting epidemiology studies on Zantac?
The 2016 Stanford study: Why was it overlooked, and what did Valisure discover?
Alerting the FDA: Why was their response tempered?
Is the high NDMA level in ranitidine due to errors or contamination?
The FDA's risk by not acting more decisively on ranitidine
What should Zantac/ranitidine users do now?
Shownotes
Transcript
No transcript made for this episode yet, you may request it for free.
